Tag: U.K.
-
Biotechs Partner on Lower Cost AI-Designed Drugs
Two biotechnology companies are collaborating on discovery and development of new drugs designed with artificial intelligence, at lower cost to patients.
-
Antibodies Help Some Hospitalized Covid-19 Patients
Results from a clinical trial show a combination of two synthetic antibodies reduces deaths in hospitalized Covid-19 patients with no earlier immune response.
-
Plant-Based Material Designed to Replace Plastics
Biochemists created a polymer film derived from soy proteins in a sustainable process that can replace many of today’s single-use plastics.
-
New Biotech Creating Precision Cancer Therapies
A biotechnology company began work in public to develop new treatments that target proteins responsible for gene expression, beginning with cancer.
-
Multiple Organs Impaired in Long Covid-19 Patients
A study of individuals with lingering symptoms from Covid-19 shows they experience impaired organ functions months after the initial infections.
-
Trial Shows Malaria Vaccine Protects Young Children
Results from a clinical trial in Burkina Faso show a high efficacy rate for a candidate vaccine to protect young children against malaria infections.
-
Challenge Trial Testing Covid-19 Reinfection
A clinical trial is underway testing immune responses from new Covid-19 infections in volunteers previously infected with the virus.
-
Novavax Joins Alternative Second Shot Vaccine Trial
Vaccine developer Novavax is taking part in a clinical trial testing effects of different Covid-19 vaccines in first and second immunizations.
-
Vaccine Spin-Off Raises $168 Million in New Funds
A developer of vaccines, including a leading Covid-19 vaccine, and cancer immunotherapies, is raising $168 million in its second venture round.
-
Two Therapies Dropped from NIH Covid-19 Trial
A clinical trial testing multiple treatments for people hospitalized with Covid-19 infections is dropping two therapies for not meeting efficacy standards.